130 related articles for article (PubMed ID: 37240602)
1. Early Evaluation of Immunotherapy Response in Lymphoma Patients by 18F-FDG PET/CT: A Literature Overview.
Ferrari C; Maggialetti N; Masi T; Nappi AG; Santo G; Niccoli Asabella A; Rubini G
J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33803667
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects.
Al-Ibraheem A; Abdlkadir AS; Juweid ME; Al-Rabi K; Ma'koseh M; Abdel-Razeq H; Mansour A
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831405
[TBL] [Abstract][Full Text] [Related]
3. Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy.
Cheson BD; Ansell S; Schwartz L; Gordon LI; Advani R; Jacene HA; Hoos A; Barrington SF; Armand P
Blood; 2016 Nov; 128(21):2489-2496. PubMed ID: 27574190
[TBL] [Abstract][Full Text] [Related]
4. The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy.
Jia W; Gao Q; Han A; Zhu H; Yu J
Cancer Biol Med; 2019 Nov; 16(4):655-670. PubMed ID: 31908886
[TBL] [Abstract][Full Text] [Related]
5. From immune equilibrium to tumor ecodynamics.
Chen X
Front Oncol; 2024; 14():1335533. PubMed ID: 38807760
[TBL] [Abstract][Full Text] [Related]
6. Dissociated response to PD-1 inhibitors combined with radiotherapy in patients with advanced metastatic solid tumors: a single-center experience.
Yu Q; Zhang H; Song Y; Chen C; Chen J; Shen J
World J Surg Oncol; 2023 Jul; 21(1):228. PubMed ID: 37501167
[TBL] [Abstract][Full Text] [Related]
7. Response Assessment of Primary Liver Tumors to Novel Therapies: an Imaging Perspective.
Ansari G; Mirza-Aghazadeh-Attari M; Mohseni A; Madani SP; Shahbazian H; Pawlik TM; Kamel IR
J Gastrointest Surg; 2023 Oct; 27(10):2245-2259. PubMed ID: 37464140
[TBL] [Abstract][Full Text] [Related]
8. Advances in PET/CT Imaging for Breast Cancer.
de Jong D; Desperito E; Al Feghali KA; Dercle L; Seban RD; Das JP; Ma H; Sajan A; Braumuller B; Prendergast C; Liou C; Deng A; Roa T; Yeh R; Girard A; Salvatore MM; Capaccione KM
J Clin Med; 2023 Jul; 12(13):. PubMed ID: 37445572
[TBL] [Abstract][Full Text] [Related]
9. Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma.
Nisnboym M; Vincze SR; Xiong Z; Sneiderman CT; Raphael RA; Li B; Jaswal AP; Sever RE; Day KE; LaToche JD; Foley LM; Karimi H; Hitchens TK; Agnihotri S; Hu B; Rajasundaram D; Anderson CJ; Blumenthal DT; Pearce TM; Uttam S; Nedrow JR; Panigrahy A; Pollack IF; Lieberman FS; Drappatz J; Raphael I; Edwards WB; Kohanbash G
Cancer Res Commun; 2023 Jul; 3(7):1173-1188. PubMed ID: 37426447
[TBL] [Abstract][Full Text] [Related]
10. Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction.
Song R; Liu F; Ping Y; Zhang Y; Wang L
Biomark Res; 2023 Jun; 11(1):57. PubMed ID: 37268978
[TBL] [Abstract][Full Text] [Related]
11. Advances in PET imaging of cancer.
Schwenck J; Sonanini D; Cotton JM; Rammensee HG; la Fougère C; Zender L; Pichler BJ
Nat Rev Cancer; 2023 Jul; 23(7):474-490. PubMed ID: 37258875
[TBL] [Abstract][Full Text] [Related]
12. The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review.
Kiamanesh Z; Ayati N; Sadeghi R; Hawkes E; Lee ST; Scott AM
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4661-4676. PubMed ID: 35932329
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of 2-[
Manson G; Lemchukwu AC; Mokrane FZ; Lopci E; Aide N; Vercellino L; Houot R; Dercle L
Eur Radiol; 2022 Sep; 32(9):6536-6544. PubMed ID: 35344061
[TBL] [Abstract][Full Text] [Related]
14. Early
Chen A; Mokrane FZ; Schwartz LH; Morschhauser F; Stamatoullas A; Schiano de Colella JM; Vercellino L; Casasnovas O; Chauchet A; Delmer A; Nicolas-Virelizier E; Ghesquières H; Moles-Moreau MP; Schmitt A; Dulery R; Bouabdallah K; Borel C; Touati M; Deau-Fischer B; Peyrade F; Seban RD; Manson G; Armand P; Houot R; Dercle L
J Nucl Med; 2020 May; 61(5):649-654. PubMed ID: 31628220
[TBL] [Abstract][Full Text] [Related]
15.
Dercle L; Seban RD; Lazarovici J; Schwartz LH; Houot R; Ammari S; Danu A; Edeline V; Marabelle A; Ribrag V; Michot JM
J Nucl Med; 2018 Jan; 59(1):15-24. PubMed ID: 28596157
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Response to Immunotherapy in Patients with Hodgkin Lymphoma: Towards Quantifying Changes in Tumor Burden Using FDG-PET/CT.
Tutino F; Giovannini E; Chiola S; Giovacchini G; Ciarmiello A
J Clin Med; 2023 May; 12(10):. PubMed ID: 37240602
[TBL] [Abstract][Full Text] [Related]
17.
Tamayo P; Martín A; Díaz L; Cabrero M; García R; García-Talavera P; Caballero D
Rev Esp Med Nucl Imagen Mol; 2017; 36(5):312-321. PubMed ID: 28483374
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
